Published in Aust N Z J Public Health on December 01, 1998
Why we object to NAOMI. Heroin maintenance in Canada. Can Fam Physician (2006) 1.43
Predictors of attrition from a national sample of methadone maintenance patients. Am J Drug Alcohol Abuse (2010) 1.07
Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials. Diabetologia (2012) 2.53
HIV prevalence and risk behaviours for HIV transmission in South Australian prisons. AIDS (1991) 2.30
Heroin overdose: the case for take-home naloxone. BMJ (1996) 2.25
Hyperalgesic responses in methadone maintenance patients. Pain (2001) 2.09
Defining the minimum level of detectable change for the Roland-Morris questionnaire. Phys Ther (1996) 1.97
Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev (2008) 1.79
Experience of non-fatal overdose among heroin users in Adelaide, Australia: circumstances and risk perceptions. Addiction (1998) 1.75
Evidence-based practices for services to families of people with psychiatric disabilities. Psychiatr Serv (2001) 1.73
Assessing change over time in patients with low back pain. Phys Ther (1994) 1.68
Alpha2 adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst Rev (2004) 1.59
Nutritional survey of Bangladeshi children aged under 5 years in the London borough of Tower Hamlets. Arch Dis Child (1983) 1.56
Nipah virus infection among abattoir workers in Malaysia, 1998-1999. Int J Epidemiol (2001) 1.54
Bacillus spp. among hospitalized patients with haematological malignancies: clinical features, epidemics and outcomes. J Hosp Infect (2006) 1.44
Personalizing healthcare: from genetics through payment to improving care? J R Soc Med (2013) 1.40
Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev (2004) 1.35
The abbreviated impactor measurement (AIM) concept: part 1--Influence of particle bounce and re-entrainment-evaluation with a "dry" pressurized metered dose inhaler (pMDI)-based formulation. AAPS PharmSciTech (2009) 1.34
A review of biological indicators of illicit drug use, practical considerations and clinical usefulness. Addiction (1999) 1.32
HIV prevalence and risk behaviour in needle exchange attenders: a national study. The Collaboration of Australian Needle Exchanges. Med J Aust (1997) 1.26
Buprenorphine for the management of opioid withdrawal. Cochrane Database Syst Rev (2006) 1.23
Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort. Neurology (2011) 1.22
Oxygen free radicals and systemic autoimmunity. Clin Exp Immunol (2003) 1.22
Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database Syst Rev (2005) 1.21
Buprenorphine for the management of opioid withdrawal. Cochrane Database Syst Rev (2004) 1.18
The aging paradox: free radical theory of aging. Exp Gerontol (1999) 1.15
Increased intraocular pressure on the first postoperative day following resident-performed cataract surgery. Eye (Lond) (2011) 1.14
Relationship between circulating levels of IFN-gamma, IL-10, CXCL9 and CCL2 in pulmonary and extrapulmonary tuberculosis is dependent on disease severity. Scand J Immunol (2009) 1.13
The abbreviated impactor measurement (AIM) concept: part II--Influence of evaporation of a volatile component-evaluation with a "droplet-producing" pressurized metered dose inhaler (pMDI)-based formulation containing ethanol as cosolvent. AAPS PharmSciTech (2009) 1.12
Binding of monoclonal anti-native DNA autoantibodies to DNA of varying size and conformation. Mol Immunol (1985) 1.10
A strategy for reducing maternal mortality. Bull World Health Organ (1999) 1.09
Allergy in systemic lupus erythematosus. IgE levels and reaginic phenomenon. Arthritis Rheum (1976) 1.07
Pharmaceutical company-sponsored promotions. Fam Med (1991) 1.07
Alpha2 adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst Rev (2001) 1.06
Whole exome sequencing unravels disease-causing genes in consanguineous families in Qatar. Clin Genet (2013) 1.06
A longitudinal study of children exposed to sulfur oxides. Am J Epidemiol (1985) 1.04
Subcutaneous metallic mercury injection of the hand. Br J Plast Surg (2003) 1.02
Cokeromyces recurvatus, a mucoraceous zygomycete rarely isolated in clinical laboratories. J Clin Microbiol (1994) 0.99
Linkage mapping around the ragged (Ra) and wasted (wst) loci on distal mouse chromosome 2. Genomics (1994) 0.98
Antibodies from patients with mixed connective tissue disease react with heterogeneous nuclear ribonucleoprotein or ribonucleic acid (hnRNP/RNA) of the nuclear matrix. J Immunol (1984) 0.98
Emergency medicine in China: redefining a specialty. J Emerg Med (2001) 0.97
Bloody needles: the volumes of blood transferred in simulations of needlestick injuries and shared use of syringes for injection of intravenous drugs. AIDS (1991) 0.96
Alpha2 adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst Rev (2003) 0.95
Does experience influence judgments of pain behaviour? Evidence from relatives of pain patients and therapists. Pain Res Manag (2001) 0.94
Explaining attitudes toward medication compliance among a seriously mentally ill population. J Nerv Ment Dis (1994) 0.94
Comparative physiology of salt tolerance in Candida tropicalis and Saccharomyces cerevisiae. Microbiology (1997) 0.93
Polyamine induced Z-conformation of native calf thymus DNA. FEBS Lett (1995) 0.92
Severe bone marrow necrosis without suggestive features. Am J Hematol (2006) 0.92
Nipah virus among military personnel involved in pig culling during an outbreak of encephalitis in Malaysia, 1998-1999. Emerg Infect Dis (2001) 0.92
Real-time ultrasonographic analysis of the normal postpartum uterus: technique, variability, and measurements. J Ultrasound Med (1994) 0.91
Describing and evaluating jail diversion services for persons with serious mental illness. Psychiatr Serv (1999) 0.91
A randomised controlled trial of sublingual buprenorphine-naloxone film versus tablets in the management of opioid dependence. Drug Alcohol Depend (2013) 0.90
Hepatitis C and the history of injecting drug use in South Australia. Med J Aust (1994) 0.90
Measurement and significance of 3-nitrotyrosine in systemic lupus erythematosus. Scand J Immunol (2006) 0.88
Advanced actinomycotic pelvic inflammatory disease simulating gynecologic malignancy. A report of two cases. J Reprod Med (1991) 0.88
'Bare below the elbows' and quality of hand washing: a randomised comparison study. J Hosp Infect (2009) 0.88
The effect of anti-Z-DNA antibodies on the B-DNA-Z-DNA equilibrium. J Biol Chem (1986) 0.88
A computational model of cholinergic disruption of septohippocampal activity in classical eyeblink conditioning. Neurobiol Learn Mem (1996) 0.88
Neonatal outcomes of pregnancy complicated by idiopathic thrombocytopenic purpura. J Perinatol (2009) 0.88
The varieties of readmission: the case against the use of recidivism rates as a measure of program effectiveness. Am J Orthopsychiatry (1979) 0.87
Crossreactivity of SLE autoantibodies with 70 kDa heat shock proteins of Mycobacterium tuberculosis. Microbiol Immunol (2001) 0.86
Buprenorphine for the management of opioid withdrawal. Cochrane Database Syst Rev (2002) 0.86
Self-help groups for families of persons with mental illness: perceived benefits of helpfulness. Community Ment Health J (1999) 0.86
Serologic and virologic surveillance of avian influenza in Nigeria, 2006-7. Euro Surveill (2008) 0.86
Subtypes of dissociative (conversion) disorder in two tertiary hospitals in Bangladesh. Mymensingh Med J (2010) 0.85
A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD). Addict Behav (2005) 0.85
Worrying about normality. Crit Care Resusc (2002) 0.85
Interaction of amiloride and one of its derivatives with Vpu from HIV-1: a molecular dynamics simulation. FEBS Lett (2004) 0.85
Structure and immunological function of oxidised albumin in lung cancer: its potential role as a biomarker of elevated oxidative stress. Br J Biomed Sci (2009) 0.85
Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database Syst Rev (2002) 0.84
Identical specificity of lupus antibodies and antibodies elicited in rabbits against Sm and RNP antigens. Immunol Commun (1984) 0.84
Effects of ultraviolet irradiation and postirradiation incubation on heterogenous nuclear RNA size in murine cells. Biophys J (1978) 0.84
Reactive oxygen species damaged human serum albumin in patients with hepatocellular carcinoma. J Exp Clin Cancer Res (2007) 0.84
Nucleic acid-8-methoxypsoralen crosslinks bind monoclonal anti-Z-DNA antibody. Biochem Mol Biol Int (1996) 0.84
Short-term temporal variation in PM2.5 mass and chemical composition during the Atlanta Supersite Experiment, 1999. J Air Waste Manag Assoc (2003) 0.83
Soft-tissue expansion before total knee arthroplasty in arthrodesed joints. A report of two cases. J Bone Joint Surg Br (1994) 0.83
Human autoantibody binding to multiple conformations of DNA. Biochem Int (1992) 0.83
Reactive oxygen species modified DNA fragments of varying size are the preferred antigen for human anti-DNA autoantibodies. Immunol Lett (1992) 0.83
Case manager alliance with clients in an older cohort. Community Ment Health J (1996) 0.83
Binding of human anti-DNA autoantibodies to reactive oxygen species modified-DNA and probing oxidative DNA damage in cancer using monoclonal antibody. Int J Cancer (1998) 0.82
Generation of small mutation in large genomic fragments by homologous recombination: description of the technique and examples of its use. Nucleic Acids Res (1990) 0.82
Reconceptualizing assumptions about community mental health. Hosp Community Psychiatry (1986) 0.82
Effects of an amino acid solution enriched with either branched chain amino acids or ornithine-alpha-ketoglutarate on the postoperative intracellular amino acid concentration of skeletal muscle. Br J Surg (1990) 0.82
Small cell lung cancer presenting as acute leukaemia. Cytopathology (2005) 0.82
Opioid antagonists and adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst Rev (2000) 0.81
Role of nitric oxide modified DNA in the etiopathogenesis of systemic lupus erythematosus. Lupus (2004) 0.81
Enzyme-linked immunosorbent assay for anti-DNA antibodies using fluorogenic and colorigenic substrates. J Immunol Methods (1983) 0.81
Polynucleotide specificity of anti-reactive oxygen species (ROS) DNA antibodies. Clin Exp Immunol (1993) 0.81
The impact of cannabis decriminalisation in Australia and the United States. J Public Health Policy (2000) 0.81
Releasing information to families of persons with severe mental illness: a survey of NAMI members. Psychiatr Serv (2000) 0.81
Rates of HIV infection among probationers and parolees with mental illness. Psychiatr Serv (2001) 0.81
A randomized clinical trial to compare the efficacy of erythromycin, ampicillin and tetracycline for the treatment of cholera in children. Trans R Soc Trop Med Hyg (1998) 0.80
Antibodies against DNA-psoralen crosslink recognize unique conformation. Biochim Biophys Acta (1991) 0.80
Physical and mental health problems in amphetamine users from metropolitan Adelaide, Australia. Drug Alcohol Rev (1998) 0.80
Musculoskeletal histoplasmosis. A case report and review of the literature. J Bone Joint Surg Am (2001) 0.80
Antigen binding characteristics of antibodies against hydroxyl radical modified thymidine monophosphate. Immunol Lett (2000) 0.80
Sensitivity of Sickness Impact Profile items to measure change over time in a low-back pain patient group. Spine (Phila Pa 1976) (1993) 0.80
Buprenorphine for the management of opioid withdrawal. Cochrane Database Syst Rev (2000) 0.80
On the conformational state of photoinactivated tyrosinase: possibility of structural segments in the enzyme molecule. J Radiat Res (1985) 0.80
Immunochemical detection of oxidative DNA damage in cancer and aging using anti-reactive oxygen species modified DNA monoclonal antibody. Int J Biochem Cell Biol (1998) 0.79
Treatment of recurrent and metastatic endometrial cancer with cisplatin, doxorubicin, cyclophosphamide, and megestrol acetate. Gynecol Oncol (1989) 0.79